Chemoinformaics analysis of 4-(beta-D-glucosyloxy)benzoic acid
| Molecular Weight | 300.263 | nRot | 4 |
| Heavy Atom Molecular Weight | 284.135 | nRig | 13 |
| Exact Molecular Weight | 300.085 | nRing | 2 |
| Solubility: LogS | -1.541 | nHRing | 1 |
| Solubility: LogP | -0.706 | No. of Aliphatic Rings | 1 |
| Acid Count | 1 | No. of Aromatic Rings | 1 |
| Base Count | 0 | No. of Aliphatic Carbocycles Rings | 0 |
| Atoms Count | 37 | No. of Aliphatic Hetero Cycles | 1 |
| No. of Heavy Atom | 21 | No. of Aromatic Carbocycles | 1 |
| nHetero | 8 | No. of Aromatic Hetero Cycles | 0 |
| nBridge Head | 0 | No. Saturated Carbocycles | 0 |
| No. of Hydrogen atom | 16 | No. of Saturated Hetero Cycles | 1 |
| No. of Carbon atom | 13 | No. of Saturated Rings | 1 |
| No. of Nitrogen atom | 0 | No. of Arom Atom | 6 |
| No. of Oxygen atom | 8 | No. of Arom Bond | 6 |
| nHA | 7 | APOL | 38.7947 |
| nHD | 5 | BPOL | 20.3913 |
| QED | 0.456 |
| Synth | 3.257 |
| Natural Product Likeliness | 1.557 |
| NR-PPAR-gamma | 0.006 |
| Lipinski | Accepted |
| Pfizer | Accepted |
| GSK | Accepted |
| Golden Triangle | Accepted |
| Pgp-inh | 0.001 |
| Pgp-sub | 0.027 |
| HIA | 0.866 |
| CACO-2 | -6.182 |
| MDCK | 0.000240441 |
| BBB | 0.626 |
| PPB | 0.251495 |
| VDSS | 0.254 |
| FU | 0.58105 |
| CYP1A2-inh | 0.029 |
| CYP1A2-sub | 0.024 |
| CYP2c19-inh | 0.015 |
| CYP2c19-sub | 0.048 |
| CYP2c9-inh | 0.001 |
| CYP2c9-sub | 0.072 |
| CYP2d6-inh | 0.008 |
| CYP2d6-sub | 0.116 |
| CYP3a4-inh | 0.012 |
| CYP3a4-sub | 0.009 |
| CL | 1.613 |
| T12 | 0.646 |
| hERG | 0.1 |
| Ames | 0.027 |
| ROA | 0.032 |
| SkinSen | 0.057 |
| Carcinogencity | 0.086 |
| EI | 0.015 |
| Respiratory | 0.025 |
| NR-Aromatase | 0.005 |
| Antiviral | Yes |
| Prediction | 0.800292 |